313 related articles for article (PubMed ID: 16166579)
1. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.
Demchuk AM; Hill MD; Barber PA; Silver B; Patel SC; Levine SR;
Stroke; 2005 Oct; 36(10):2110-5. PubMed ID: 16166579
[TBL] [Abstract][Full Text] [Related]
2. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
[TBL] [Abstract][Full Text] [Related]
3. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
[TBL] [Abstract][Full Text] [Related]
4. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
6. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
[TBL] [Abstract][Full Text] [Related]
7. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
8. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
Kent DM; Ruthazer R; Selker HP
Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
[TBL] [Abstract][Full Text] [Related]
10. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
Hill MD; Rowley HA; Adler F; Eliasziw M; Furlan A; Higashida RT; Wechsler LR; Roberts HC; Dillon WP; Fischbein NJ; Firszt CM; Schulz GA; Buchan AM;
Stroke; 2003 Aug; 34(8):1925-31. PubMed ID: 12843342
[TBL] [Abstract][Full Text] [Related]
11. Middle Cerebral Artery Residual Contrast Stagnation on Noncontrast CT Scan Following Endovascular Treatment in Acute Ischemic Stroke Patients.
Payabvash S; Qureshi MH; Taleb S; Pawar S; Qureshi AI
J Neuroimaging; 2015; 25(6):946-51. PubMed ID: 25684437
[TBL] [Abstract][Full Text] [Related]
12. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
13. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke.
Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ
J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
[TBL] [Abstract][Full Text] [Related]
16. Impact of window setting optimization on accuracy of computed tomography and computed tomography angiography source image-based Alberta Stroke Program Early Computed Tomography Score.
Arsava EM; Saarinen JT; Unal A; Akpinar E; Oguz KK; Topcuoglu MA
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):12-6. PubMed ID: 22748712
[TBL] [Abstract][Full Text] [Related]
17. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD
Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous thrombolysis patients with acute ischemic stroke--the analysis of the 100 cases. Part II. Neuroimaging, the analysis of hemorrhagic complications and deaths].
Sobolewski P; Sledzińska M; Szczuchniak W; Grzesik M; Sobota A; Hatalska-Zerebiec R
Przegl Lek; 2012; 69(6):242-6. PubMed ID: 23094436
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
